Thus, our data support studies that identify Crk in signaling upstream of Cdc42 [45] and demonstrates that 1833TR breast tumor cells are dependent, at least in part, on Crk for activation of this GTPase, providing a potential mechanism for diminished in vivo tumor growth, as well as cell migration and invasion that are required for metastatic spread. The gene discussed is CRK; the disease is neoplasm.